Novo Nordisk’s Ozempic and Wegovy continue to outpace Eli Lilly’s Mounjaro and Zepbound, even though the latter are demonstrably more effective in clinical trials. The most recent earnings reports ...
I wonder if 2025 will be the year sensible health advice of the sort the late Michael Mosley specialised in (eat proper food, take regular exercise, drink moderately) will be finally, wilfully ...
For weight loss drugs like Ozempic and Wegovy, 2024 was a big year. More patients are relying on them to manage their weight, treat diabetes, or prevent heart attacks and strokes. And while they are ...
While West Virginia's employee health insurance program covers drugs like Ozempic for people with type 2 diabetes, officials decided to indefinitely pause covering their use for weight loss patients ...